← Back to Search

Dietary Supplement

Health and Wellness Products for Pain

N/A
Recruiting
Led By Emily K. Pauli, PharmD
Research Sponsored by Radicle Science
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Selects pain and/or looking to improve their pain as a reason for their interest in taking a health and wellness product
Expresses a willingness to take a study product and not know the product identity (active or placebo) until the end of the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial tested products to see if they could help reduce pain and improve overall health.

Who is the study for?
Adults over 21 in the US who want to reduce pain with health and wellness products can join. They must be willing to take an unknown product (active or placebo) until study's end, not be pregnant/breastfeeding, have no severe heart/liver/kidney disease, not on conflicting meds like anticoagulants/high-dose steroids/MAOIs, and not heavy drinkers.Check my eligibility
What is being tested?
The trial is testing different health and wellness products against placebos to see if they help with various types of pain. Participants are randomly assigned a real product or a fake one without knowing which they received until the study concludes.See study design
What are the potential side effects?
Since this is about general health and wellness products for pain relief, specific side effects aren't listed but could range from none to potential mild discomfort depending on individual reactions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am interested in a health product to manage or improve my pain.
Select...
I am willing to take a study drug without knowing if it's active or a placebo.
Select...
I am 21 years old or older.
Select...
My main goal is to reduce my pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in pain interference
Secondary outcome measures
Change in energy (fatigue)
Change in feelings of anxiety
Change in neuropathic pain
+7 more
Other outcome measures
Change in focus (cognitive function)
Change in libido
Change in mood (emotional distress-depression)

Trial Design

9Treatment groups
Experimental Treatment
Placebo Group
Group I: Active Product 3.3Experimental Treatment1 Intervention
Relief Product Form 3 - active product 3
Group II: Active Product 3.2Experimental Treatment1 Intervention
Relief Product Form 3 - active product 2
Group III: Active Product 3.1Experimental Treatment1 Intervention
Relief Product Form 3 - active product 1
Group IV: Active Product 2.1Experimental Treatment1 Intervention
Relief Product Form 2 - active product 1
Group V: Active Product 1.2Experimental Treatment1 Intervention
Relief Product Form 1 - active product 2
Group VI: Active Product 1.1Experimental Treatment1 Intervention
Relief Product Form 1 - active product 1
Group VII: Placebo Control 2Placebo Group1 Intervention
Relief Product Form 2 - control
Group VIII: Placebo Control 1Placebo Group1 Intervention
Relief Product Form 1 - control
Group IX: Placebo Control 3Placebo Group1 Intervention
Relief Product Form 3 - control

Find a Location

Who is running the clinical trial?

Radicle ScienceLead Sponsor
17 Previous Clinical Trials
32,783 Total Patients Enrolled
1 Trials studying Nociceptive Pain
457 Patients Enrolled for Nociceptive Pain
Emily K. Pauli, PharmDPrincipal InvestigatorRadicle Science, Inc
13 Previous Clinical Trials
25,256 Total Patients Enrolled
1 Trials studying Nociceptive Pain
457 Patients Enrolled for Nociceptive Pain

Media Library

Nociceptive Pain Clinical Trial 2023: Placebo Control Form 1 Highlights & Side Effects. Trial Name: NCT05837923 — N/A
Placebo Control Form 1 (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05837923 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the requisite qualifications for those enrolling in this experiment?

"This research is accepting 900 participants who are aged between 21 and 105, all of whom must have nociceptive pain."

Answered by AI

Are geriatric patients excluded from this experimental protocol?

"The criteria for enrollment in this medical trial stipulates that participants must be aged between 21 and 105. 81 studies are reserved for those below the age of majority, while 379 have been designated to seniors over 65 years old."

Answered by AI

Is enrollment still open for this experiment?

"Affirmative. According to clinicaltrials.gov, this medical trial is presently searching for suitable participants and was initially posted on April 3rd 2023 with the most recent update made on April 27th of the same year."

Answered by AI

To what extent has enrollment grown for this trial?

"Yes, the clinicaltrials.gov website confirms that this medical trial is still recruiting patients; it was posted on April 3rd 2023 and last edited a month later. 900 individuals are required from one particular site."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

I have pain in both knees. Fingers,.
PatientReceived 1 prior treatment
~1905 spots leftby Jun 2024